Kourosh Davarpanah, Inato CEO
Big Pharma-partnered clinical trial matchmaker secures $20M to improve platform
A company with public links to Sanofi and Moderna has raised more money to expand its mission of improving diversity and enrollment in clinical trials.
Inato put the word out on Wednesday that it raised $20 million via an A2 round to advance its matching platform between pharma companies and potential clinical trial sites.
Inato CEO Kourosh Davarpanah told Endpoints News that with the $20 million in hand, it will pursue improvements to its diversity offerings, its focus on oncology and data collection.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters